CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
294-90-6 | 輪環(huán)藤寧; 1,4,7,10-四氮雜環(huán)十二烷 | Cyclen; 1,4,7,10-Tetraazacyclododecane | ![]() | C8H20N4 | 詳情 | 供應(yīng)商 |
155148-31-5 | 1,1'-[1,4-亞苯基雙(亞甲基)]雙[1,4,8,11-四氮雜環(huán)十四烷] | 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-Tetraazacyclotetradecane]; AMD 3100 | ![]() | C28H54N8 | 詳情 | 供應(yīng)商 |
127072-57-5 | Sporidesmolide V (9CI); SporidesmolideI, 2-D-alloisoleucine-4-(4-methyl-L-2-hydroxypentanoic acid)-; 1,10-Dioxa-4,7,13,16-Tetraazacyclooctadecane, cyclic peptide deriv.; Cyclo(D-alloisoleucyl-D-leucyl-4-methyl-L-2-hydroxypentanoyl-L-valyl-N-methyl-L-leucyl-3-methyl-L-2-hydroxybutanoyl) | ![]() | C35H62N4O8 | 詳情 | 供應(yīng)商 | |
2900-38-1 | Sporidesmolide I(6CI,8CI,9CI); Sporidesmolide1 (7CI); 1,10-Dioxa-4,7,13,16-Tetraazacyclooctadecane, cyclic peptide deriv.; Cyclo(3-methyl-L-2-hydroxybutanoyl-D-valyl-D-leucyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-N-methyl-L-leucyl); Cyclo(D-valyl-D-leucyl-L-a-hydroxyisovaleryl-L-valyl-N-methyl-L-leucyl-L-a-hydroxyisovaleryl) | ![]() | C33H58N4O8 | 詳情 | 供應(yīng)商 | |
3200-75-7 | Sporidesmolide II(7CI,8CI,9CI); SporidesmolideI, 2-D-alloisoleucine-; 1,10-Dioxa-4,7,13,16-Tetraazacyclooctadecane, cyclicpeptide deriv.; Cyclo(D-alloisoleucyl-D-leucyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-N-methyl-L-leucyl-3-methyl-L-2-hydroxybutanoyl); Cyclo(D-alloisoleucyl-D-leucyl-L-a-hydroxyisovaleryl-L-valyl-N-methyl-L-leucyl-L-a-hydroxyisovaleryl) | ![]() | C34H60N4O8 | 詳情 | 供應(yīng)商 | |
60239-18-1 | 1,4,7,10-四氮雜環(huán)十二烷-N,N,N,N-四乙酸 | 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraaceticacid; 1,4,7,10-Tetra(carboxymethyl)-1,4,7,10-Tetraazacyclododecane; 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid; DOTA; NSC681107; Tetraxetan | ![]() | C16H28N4O8 | 詳情 | 供應(yīng)商 |
144602-02-8 | 11-21-Endothelin 1(swine reduced), cyclic (11®15)-disulfide; Endothelin1 (pig reduced), 1-de-L-cysteine-2-de-L-serine-3-de-L-cysteine-4-de-L-serine-5-de-L-serine-6-de-L-leucine-7-de-L-methionine-8-de-L-asparticacid-9-de-L-lysine-10-de-L-glutamic acid-, cyclic (11® 15)-disulfide; 1,2-Dithia-5,8,11,14-Tetraazacycloheptadecane, cyclic peptide deriv.; IRL 1038 | ![]() | C68H92N14O15S2 | 詳情 | 供應(yīng)商 | |
293-40-3 | 1,3,5,7,2,4,6,8-Tetrathiatetrazocine(6CI,7CI,8CI,9CI); 1,3,5,7-Tetrathia-2,4,6,8-Tetraazacyclooctane; Tetrasulfur tetraimide | ![]() | H4N4S4 | 詳情 | 供應(yīng)商 | |
111479-37-9 | 1,4,8,11-Tetraazacyclotetradecane-1-propanamine,4-methyl-; 1-(3-Aminopropyl)-4-methyl-1,4,8,11-Tetraazacyclotetradecane | ![]() | C14H33N5 | 詳情 | 供應(yīng)商 | |
18304-79-5 | 1,3,6,8-Tetraazatricyclo[6.2.1.13,6]dodecane; 1,3,6,8-Diendomethylene-1,3,6,8-Tetraazacyclodecane; Dimtac; NSC 4436 | ![]() | C8H16N4 | 詳情 | 供應(yīng)商 | |
6054-74-6 | 1,3,5,7-Tetrazocine,octahydro-; 1,3,5,7-Tetraazacyclooctane; Octahydro-1,3,5,7-tetrazocine; s-Tetrazocine, octahydro- | ![]() | C4H12N4 | 詳情 | 供應(yīng)商 | |
175854-50-9 | 1,4,7,10-Tetraazacyclododecane,1,1'-[1,2-phenylenebis(methylene)]bis- (9CI); 1,1’-[1,2-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,7,10-TetraazacycloDODECANE) OCTAHYDROCHLORIDE; BISCYCLEN ORTHO; 1,1’-[1,2-Phenylenebis-(methylene)]-bis-(1,4,7,10-Tetraazacyclododecane) octahydrochloride (9CI), 95 % | ![]() | C24H46N8 | 詳情 | 供應(yīng)商 | |
110078-46-1 | 1,4,8,11-Tetraazacyclotetradecane,1,1'-[1,4-phenylenebis(methylene)]bis-; 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-Tetraazacyclotetradecane; Mozobil; Plerixafor | ![]() | C28H54N8 | 詳情 | 供應(yīng)商 | |
393864-02-3 | 1,4,7,10-Tetraazacyclododecane,1,1'-[1,4-phenylenebis(methylene)]bis-, hexahydrochloride (9CI); BISCYCLEN PARA; 1,1’-[1,4-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,7,10-TetraazacycloDODECANE) OCTAHYDROCHLORIDE; 1,1’-[1,4-Phenylenebis-(methylene)]-bis-(1,4,7,10-Tetraazacyclododecane) octahydrochloride (9CI), 95 % | ![]() | C24H52Cl6N8 | 詳情 | 供應(yīng)商 | |
41378-98-7 | 1,3,5,7-Tetrazocine,1,3,5,7-tetraacetyloctahydro- (9CI); 1,3,5,7-Tetraaceto-1,3,5,7-Tetraazacyclooctane; TAT; TAT (explosive) | ![]() | C12H20N4O4 | 詳情 | 供應(yīng)商 | |
91987-74-5 | 1,4,7,10- | ![]() | C12H32N4O12P4 | 詳情 | 供應(yīng)商 | |
5162-63-0 | 1,3,5,7-TETRAMETHYL-1,3,5,7-TETRAVINYLCYCLOTETRASILAZANE; 1,3,5,7-TETRAVINYL-1,3,5,7-TETRAMETHYLCYCLOTETRASILAZANE; 1,3,5,7-TETRAMETHYL-1,3,5,7-TETRAVINYLCYCLOTETRASILAZANE; 2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasilazane; 1,3,5,7-TETRAVINYL-1,3,5,7-TETRAMETHYLCYCLOTETRASILAZANE 95%; 1,3,5,7-Tetramethyl-1,3,5,7-tetravinyl-1,3,5,7-tetrasila-2,4,6,8-Tetraazacyclooctane; 2,4,6,8-Tetraethenyl-2,4,6,8-tetramethylcyclooctanetetrasilazane; 2,4,6,8-Tetravinyl-2,4,6,8-tetramethylcyclooctanetetrasilazane; 2,4,6,8-tetra(ethenyl)-2,4,6,8-tetramethyl-1,3,5,7,2,4,6,8-tetrazatetrasilocane | ![]() | C12H28N4Si4 | 詳情 | 供應(yīng)商 | |
155148-32-6 | 1,1'-[1,4-亞苯基雙(亞甲基)]雙(1,4,8,11-四氮雜環(huán)十四烷)八氫溴酸鹽 | 1,1'-[1,4-Phenylenebis(methylene)]bis(1,4,8,11-Tetraazacyclotetradecane) octahydrobromide; 1,1'-[1,4-Phenylenebis(methylene)]bis(1,4,8,11-Tetraazacyclotetradecane) octahydrobromide; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-Tetraazacyclotetradecane]OctahydrobromideDihydrate | ![]() | C28H62Br8N8 | 詳情 | 供應(yīng)商 |
133587-10-7 | 1,1'-[1,3-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,7,10-TetraazacycloDODECANE) OCTAHYDROCHLORIDE; 1,1'-[1,3-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,7,10-TetraazacycloDODECANE) OCTAHYDROCHLORIDE; BISCYCLEN META; 1,1'-[1,3-Phenylenebis-(methylene)]-bis-(1,4,7,10-Tetraazacyclododecane) octahydrochloride (9CI), 95 % | ![]() | C24H54Cl8N8 | 詳情 | 供應(yīng)商 | |
110078-44-9 | 1,1'-[1,3-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,8,11-TetraazacycloTETRADECANE) OCTAHYDROCHLORIDE; BISCYCLAM; 1,1'-[1,3-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,8,11-TetraazacycloTETRADECANE) OCTAHYDROCHLORIDE; 1,1'-[1,3-Phenylenebis-(methylene)]-bis-(1,4,8,11-Tetraazacyclotetradecane) octahydrochloride (9CI), 95 % | ![]() | C28H62Cl8N8 | 詳情 | 供應(yīng)商 |